


Wolverine Stack 10mg TB-500 + BPC-157
Wolverine Stack is an investigational peptide blend containing TB-500 and BPC-157. Both compounds have primarily been studied in preclinical research for their involvement in tissue-repair, cellular signalling and regenerative pathways. Human evidence remains very...
Wolverine Stack is an investigational peptide blend containing TB-500 and BPC-157. Both compounds have primarily been studied in preclinical research for their involvement in tissue-repair, cellular signalling and regenerative pathways. Human evidence remains very limited, particularly for TB-500.
Research areas include: tissue-repair pathways, wound-healing research, cellular migration, inflammation-related pathways, connective-tissue research and regenerative signalling. However, there is no established human clinical evidence for the specific TB-500 + BPC-157 combination, and research on other formulations or administration routes cannot automatically be applied to this self-mix formulation.
Important: TB-500 and BPC-157 are not approved medicines for general human use, and the specific 10mg self-mix vial shown here has not been clinically validated as a combination treatment. FDA has identified potential safety concerns involving immunogenicity and peptide-related impurities for both compounds. This product is provided for research purposes only and is not intended to diagnose, treat, cure or prevent any disease or medical condition.
| Form | Lyophilised powder |
| Purity (HPLC) | 99%+ |
| Appearance | White lyophilised solid |
| Solubility | Bacteriostatic / sterile water |
| Storage | Lyophilised at -20°C, reconstituted at 2 to 8°C |
The Certificate of Analysis for lot GX-2026 confirms an HPLC purity of 99%+ and identity confirmed by mass spectrometry.
View in COA libraryThe Safety Data Sheet describes handling, storage and disposal information for this research compound. Always follow standard laboratory safety practice.
View in SDS libraryMore like this


Tesamorelin 30mg Growth Hormone-Releasing Factor Analog

Tirzepatide 30mg GIP/GLP-1 Receptor Agonist

Semaglutide 7mg GLP-1 Receptor Agonist
Join the research list.
New compounds, batch releases and COA drops, sent before they hit the catalogue.